| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 58,953 | |||
| Prepaid expenses | 39,875 | |||
| Total current assets | 98,828 | |||
| Right of use asset | 1,609 | |||
| Software | 135,000 | |||
| Total assets | 235,437 | |||
| Accounts payable | 7,500 | |||
| Deferred wages payable | 94,500 | |||
| Right of use liability, current portion | 1,609 | |||
| Total current liabilities | 103,609 | |||
| Accrued interest payable | 33,439 | |||
| Convertible debentures | 530,000 | |||
| Total liabilities | 667,048 | |||
| Common stock 75,000,000 shares authorized, 0.001 par value, 21,323,312 shares issued and outstanding at september 30, 2025 and june 30, 2025, respectively | 21,323 | |||
| Additional paid-in capital | 1,275,109 | |||
| Accumulated deficit | -1,728,043 | |||
| Total stockholders' equity (deficit) | -431,611 | |||
| Total liabilities and stockholders' equity (deficit) | 235,437 | |||
Nexscient, Inc. (NXNT)
Nexscient, Inc. (NXNT)